Evelo Biosciences Probability of Future Pink Sheet Price Finishing Over 0.085

EVLODelisted Stock  USD 0.09  0.17  66.00%   
Evelo Biosciences' future price is the expected price of Evelo Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Evelo Biosciences performance during a given time horizon utilizing its historical volatility. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
  
Please specify Evelo Biosciences' target price for which you would like Evelo Biosciences odds to be computed.

Evelo Biosciences Target Price Odds to finish over 0.085

The tendency of Evelo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.09 90 days 0.09 
about 83.18
Based on a normal probability distribution, the odds of Evelo Biosciences to move above the current price in 90 days from now is about 83.18 (This Evelo Biosciences probability density function shows the probability of Evelo Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Evelo Biosciences has a beta of -1.92 suggesting as returns on its benchmark rise, returns on holding Evelo Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Evelo Biosciences is expected to outperform its benchmark. Additionally Evelo Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Evelo Biosciences Price Density   
       Price  

Predictive Modules for Evelo Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evelo Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.080.090.09
Details
Intrinsic
Valuation
LowRealHigh
0.080.080.09
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evelo Biosciences. Your research has to be compared to or analyzed against Evelo Biosciences' peers to derive any actionable benefits. When done correctly, Evelo Biosciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evelo Biosciences.

Evelo Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Evelo Biosciences is not an exception. The market had few large corrections towards the Evelo Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Evelo Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Evelo Biosciences within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-4.27
β
Beta against NYSE Composite-1.92
σ
Overall volatility
1.93
Ir
Information ratio -0.26

Evelo Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Evelo Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Evelo Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Evelo Biosciences is not yet fully synchronised with the market data
Evelo Biosciences has some characteristics of a very speculative penny stock
Evelo Biosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (114.53 M) with profit before overhead, payroll, taxes, and interest of 0.
Evelo Biosciences currently holds about 92.01 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 83.0% of the company shares are held by institutions such as insurance companies

Evelo Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Evelo Pink Sheet often depends not only on the future outlook of the current and potential Evelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding4.4 M
Cash And Short Term Investments47.9 M

Evelo Biosciences Technical Analysis

Evelo Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Evelo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Evelo Biosciences. In general, you should focus on analyzing Evelo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Evelo Biosciences Predictive Forecast Models

Evelo Biosciences' time-series forecasting models is one of many Evelo Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Evelo Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Evelo Biosciences

Checking the ongoing alerts about Evelo Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Evelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evelo Biosciences is not yet fully synchronised with the market data
Evelo Biosciences has some characteristics of a very speculative penny stock
Evelo Biosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (114.53 M) with profit before overhead, payroll, taxes, and interest of 0.
Evelo Biosciences currently holds about 92.01 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 83.0% of the company shares are held by institutions such as insurance companies
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Evelo Pink Sheet

If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules